Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 9/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.59 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | DRD1 | P21728 | 3/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.47 |
| ▸ | JAK2 | O60674 | 2/20 | 0.46 |
| ▸ | TERT | O14746 | 1/20 | 0.46 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29660490 | 1.00 | FTO (0.74) | FTOMEN1MAPTHPGDCYP2C19 | |
| SCHEMBL7038220 | 0.90 | FTO (0.72) | FTOMEN1MAPTHPGDCYP2C19 | |
| SCHEMBL9626320 | 0.89 | FTO (0.74) | FTOMEN1MAPTHPGDCYP2C19 | |
| SCHEMBL7611076 | 0.89 | FTO (0.74) | FTOMEN1MAPTHPGDCYP2C19 | |
| SCHEMBL17970938 | 0.89 | FTO (0.74) | FTOMEN1MAPTHPGDCYP2C19 | |
| SCHEMBL29406840 | 0.89 | FTO (0.78) | FTOMEN1MAPTHPGDCYP2C19 | |
| SCHEMBL9428406 | 0.89 | FTO (0.74) | FTOMEN1MAPTHPGDCYP2C19 | |
| SCHEMBL25103 | 0.89 | FTO (0.78) | FTOMEN1MAPTHPGDCYP2C19 | |
| SCHEMBL13537269 | 0.87 | FTO (0.69) | FTOMEN1MAPTHPGDCYP2C19 | |
| SCHEMBL15658275 | 0.87 | FTO (0.71) | FTOMEN1MAPTHPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 340 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4348347-A2 | SYSTEM AND METHOD FOR HIGH RESOLUTION 3D NANOFABRICATION | Irradiant Technologies Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| CN-117813548-A | System and method for high resolution three-dimensional nanofabrication | 光辉科技股份有限公司 | 2024-04-02 | — | — | CN | claimed |
| WO-2022251546-A2 | SYSTEM AND METHOD FOR HIGH RESOLUTION 3D NANOFABRICATION | Irradiant Technologies Inc. (US) | 2022-12-01 | — | — | WO | claimed |
| US-9910037-B2 | Conjugation of multiple vancomycin molecules on a polyvinyl alcohol backbone for the capture of microorganisms | IRIS INTERNATIONAL, INC. (US) | 2018-03-06 | — | — | US | claimed |
| US-20160041166-A1 | CONJUGATION OF MULTIPLE VANCOMYCIN MOLECULES ON A POLYVINYL ALCOHOL BACKBONE FOR THE CAPTURE OF MICROORGANISMS | IRIS INTERNATIONAL, INC. | 2016-02-11 | — | — | US | claimed |
| WO-2014151885-A1 | CONJUGATION OF MULTIPLE VANCOMYCIN MOLECULES ON A POLYVINYL ALCOHOL BACKBONE FOR THE CAPTURE OF MICROORGANISMS | IRIS INTERNATIONAL, INC. (US) | 2014-09-25 | — | — | WO | claimed |
| US-7550447-B2 | Method for precipitating nucleic acid with visible carrier | MERCK PATENT GMBH (DE) | 2009-06-23 | — | — | US | claimed |
| US-20080227221-A1 | Fluorescence Polarization-Based Homogeneous Assay For Aflatoxins | DIACHEMIX, LLC (US) | 2008-09-18 | — | — | US | claimed |
| EP-1407272-B1 | FLUORESCENCE POLARIZATION-BASED HOMOGENOUS ASSAY FOR AFLATOXINS | DIACHEMIX LLC (US) | 2007-09-12 | — | — | EP | claimed |
| US-20070178601-A1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | EMD BIOSCIENCES, INC. | 2007-08-02 | — | — | US | claimed |
| CN-1245629-C | Fluorescence polarizaton-based homogenous assay for aflatoxins | DIACHEMIX LLC (US) | 2006-03-15 | — | — | CN | claimed |
| EP-1407272-A4 | FLUORESCENCE POLARIZATION-BASED HOMOGENOUS ASSAY FOR AFLATOXINS | DIACHEMIX LLC (US) | 2005-09-14 | — | — | EP | claimed |
| CN-1527942-A | Fluorescence polarization-based homogeneous aflatoxin detection method | ���Ǿ� | 2004-09-08 | — | — | CN | claimed |
| EP-1407272-A1 | FLUORESCENCE POLARIZATION-BASED HOMOGENOUS ASSAY FOR AFLATOXINS | Diachemix LLC (US) | 2004-04-14 | — | — | EP | claimed |
| EP-0853680-B1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | EMD BIOSCIENCES INC (US) | 2004-03-31 | — | — | EP | claimed |
| WO-2003006994-A1 | FLUORESCENCE POLARIZATION-BASED HOMOGENOUS ASSAY FOR AFLATOXINS | DIACHEMIX LLC (US) | 2003-01-23 | — | — | WO | claimed |
| EP-0853680-A4 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN INC (US) | 2000-09-13 | — | — | EP | claimed |
| EP-0853680-A1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN, INC. (US) | 1998-07-22 | — | — | EP | claimed |
| WO-1997012994-A1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN, INC. (US) | 1997-04-10 | — | — | WO | claimed |
| US-12478680-B2 | Hydrogels with biodegradable crosslinking | PROLYNX LLC (US) | 2025-11-25 | — | — | US | disclosed |
| CN-118084813-A | Macrocyclic compounds | 诺和诺德牛津研究中心有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-110691777-B | Macrocyclic compounds | 诺和诺德牛津研究中心有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-20230365514-A1 | MACROCYCLIC COMPOUNDS | NOVO NORDISK RESEARCH CENTRE OXFORD LIMITED (GB) | 2023-11-16 | — | — | US | disclosed |
| US-20230135347-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | PROLYNX LLC (US) | 2023-05-04 | — | — | US | disclosed |
| US-20220389478-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | ORYZON GENOMICS SA (ES) | 2022-12-08 | — | — | US | disclosed |
| US-11454861-B2 | Hydrogels with biodegradable crosslinking | PROLYNX LLC (US) | 2022-09-27 | — | — | US | disclosed |
| US-11225510-B2 | Modified lantibiotics and methods of making and using the modified lantibiotics | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2022-01-18 | — | — | US | disclosed |
| US-11179470-B2 | Hydrogels with biodegradable crosslinking | PROLYNX LLC (US) | 2021-11-23 | — | — | US | disclosed |
| US-11181803-B2 | Hydrogels with biodegradable crosslinking | PROLYNX LLC (US) | 2021-11-23 | — | — | US | disclosed |
| US-11034991-B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | ORYZON GENOMICS S.A. (ES) | 2021-06-15 | — | — | US | disclosed |
| US-20210169864-A1 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | MERZ PHARMA GMBH & CO KGAA (DE) | 2021-06-10 | — | — | US | disclosed |
| US-20200399232-A1 | MACROCYCLIC COMPOUNDS | ZIYLO LTD (GB) | 2020-12-24 | — | — | US | disclosed |
| US-10800747-B2 | Macrocyclic compounds | ZIYLO LTD (GB) | 2020-10-13 | — | — | US | disclosed |
| US-10736943-B2 | Silk microspheres for encapsulation and controlled release | TRUSTEES OF TUFTS COLLEGE (US) | 2020-08-11 | — | — | US | disclosed |
| US-10723716-B2 | Alpha-helix mimetics as modulators of Abeta self-assembly | NEW YORK UNIVERSITY (US) | 2020-07-28 | — | — | US | disclosed |
| US-20200199182-A1 | MODIFIED LANTIBIOTICS AND METHODS OF MAKING AND USING THE MODIFIED LANTIBIOTICS | THE TEXAS A&M UNIVERSITY SYSTEM | 2020-06-25 | — | — | US | disclosed |
| US-10577399-B2 | Modified lantibiotics and methods of making and using the modified lantibiotics | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2020-03-03 | — | — | US | disclosed |
| US-20200054756-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | PROLYNX LLC (US) | 2020-02-20 | — | — | US | disclosed |
| CN-110691777-A | Macrocyclic compounds | 兹洛有限公司 | 2020-01-14 | — | — | CN | disclosed |
| US-10398779-B2 | Hydrogels with biodegradable crosslinking | PROLYNX LLC (US) | 2019-09-03 | — | — | US | disclosed |
| US-20190209692-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | PROLYNX LLC (US) | 2019-07-11 | — | — | US | disclosed |
| US-20190209691-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | PROLYNX LLC (US) | 2019-07-11 | — | — | US | disclosed |
| US-20190085372-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | ORYZON GENOMICS SA (ES) | 2019-03-21 | — | — | US | disclosed |
| EP-3430015-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | Oryzon Genomics, S.A. (ES) | 2019-01-23 | — | — | EP | disclosed |
| WO-2018167503-A1 | MACROCYCLIC COMPOUNDS | ZIYLO LIMITED (GB) | 2018-09-20 | — | — | WO | disclosed |
| EP-2755691-B1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | PROLYNX LLC (US) | 2018-08-22 | — | — | EP | disclosed |
| US-20180170910-A1 | ALPHA-HELIX MIMETICS AS MODULATORS OF ABETA SELF-ASSEMBLY | NEW YORK UNIVERSITY (US) | 2018-06-21 | — | — | US | disclosed |
| US-20180118791-A1 | MODIFIED LANTIBIOTICS AND METHODS OF MAKING AND USING THE MODIFIED LANTIBIOTICS | THE TEXAS A&M UNIVERSITY SYSTEM | 2018-05-03 | — | — | US | disclosed |
| EP-2566334-B1 | CONTROLLED DRUG RELEASE FROM SOLID SUPPORTS | PROLYNX LLC (US) | 2018-04-18 | — | — | EP | disclosed |
| US-9939447-B2 | Methods and compositions for analyzing proteins | MONOGRAM BIOSCIENCES, INC. (US) | 2018-04-10 | — | — | US | disclosed |
| US-9910037-B2 | Conjugation of multiple vancomycin molecules on a polyvinyl alcohol backbone for the capture of microorganisms | IRIS INTERNATIONAL, INC. (US) | 2018-03-06 | — | — | US | disclosed |
| US-20170312368-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | PROLYNX LLC (US) | 2017-11-02 | — | — | US | disclosed |
| WO-2017158136-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | ORYZON GENOMICS, S.A. (ES) | 2017-09-21 | — | — | WO | disclosed |
| US-9649385-B2 | Hydrogels with biodegradable crosslinking | PROLYNX LLC (US) | 2017-05-16 | — | — | US | disclosed |
| US-9421276-B2 | Clickable polyoxetane carrier for drug delivery | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2016-08-23 | — | — | US | disclosed |
| US-20160069893-A1 | Methods and Compositions for Analyzing Proteins | MONOGRAM BIOSCIENCES, INC. (US) | 2016-03-10 | — | — | US | disclosed |
| US-20160041166-A1 | CONJUGATION OF MULTIPLE VANCOMYCIN MOLECULES ON A POLYVINYL ALCOHOL BACKBONE FOR THE CAPTURE OF MICROORGANISMS | IRIS INTERNATIONAL, INC. | 2016-02-11 | — | — | US | disclosed |
| US-20150352246-A1 | SEALANTS HAVING CONTROLLED DEGRATION | PROLYNX LLC (US) | 2015-12-10 | — | — | US | disclosed |
| EP-2925256-A1 | SEALANTS HAVING CONTROLLED DEGRADATION | Prolynx LLC (US) | 2015-10-07 | — | — | EP | disclosed |
| US-20150258204-A1 | CLICKABLE POLYOXETANE CARRIER FOR DRUG DELIVERY | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2015-09-17 | — | — | US | disclosed |
| US-9110075-B2 | Compositions for analyzing proteins | MONOGRAM BIOSCIENCES, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-8946405-B2 | Controlled release from solid supports | PROLYNX LLC (US) | 2015-02-03 | — | — | US | disclosed |
| US-20140371260-A1 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | MERZ PHARMA GMBH & CO. KGAA (GE) | 2014-12-18 | — | — | US | disclosed |
| US-20140288190-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | PROLYNX LLC (US) | 2014-09-25 | — | — | US | disclosed |
| WO-2014151885-A1 | CONJUGATION OF MULTIPLE VANCOMYCIN MOLECULES ON A POLYVINYL ALCOHOL BACKBONE FOR THE CAPTURE OF MICROORGANISMS | IRIS INTERNATIONAL, INC. (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014116717-A1 | SEALANTS HAVING CONTROLLED DEGRADATION | PROLYNX LLC (US) | 2014-07-31 | — | — | WO | disclosed |
| EP-2755691-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | Prolynx LLC (US) | 2014-07-23 | — | — | EP | disclosed |
| US-8758974-B2 | Photoresist-free micropatterning on polymer surfaces | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2014-06-24 | — | — | US | disclosed |
| US-8703907-B2 | Controlled drug release from dendrimers | PROLYNX LLC (US) | 2014-04-22 | — | — | US | disclosed |
| WO-2014036566-A1 | CLICKABLE POLYOXETANE CARRIER FOR DRUG DELIVERY | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2014-03-06 | — | — | WO | disclosed |
| US-20130243866-A1 | SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASE | TRUSTEES OF TUFTS COLLEGE (US) | 2013-09-19 | — | — | US | disclosed |
| US-20130171260-A1 | SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASE | TRUSTEES OF TUFTS COLLEGE (US) | 2013-07-04 | — | — | US | disclosed |
| US-20130123461-A1 | CONTROLLED DRUG RELEASE FROM DENDRIMERS | PROLYNX LLC (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130123487-A1 | CONTROLLED RELEASE FROM SOLID SUPPORTS | PROLYNX LLC (US) | 2013-05-16 | — | — | US | disclosed |
| EP-2571496-A1 | CONTROLLED DRUG RELEASE FROM DENDRIMERS | Prolynx Llc (US) | 2013-03-27 | — | — | EP | disclosed |
| WO-2013036847-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | PROLYNX LLC (US) | 2013-03-14 | — | — | WO | disclosed |
| WO-2013036857-A1 | SULFONE LINKERS | PROLYNX LLC (US) | 2013-03-14 | — | — | WO | disclosed |
| EP-2566334-A1 | CONTROLLED DRUG RELEASE FROM SOLID SUPPORTS | Prolynx Llc (US) | 2013-03-13 | — | — | EP | disclosed |
| US-20120329829-A1 | Dopamine Transporter Inhibitors for Use in Treatment of Movement Disorders and Other CNS Indications | PREXA PHARMACEUTICALS, INC. (US) | 2012-12-27 | — | — | US | disclosed |
| US-8258305-B2 | Dopamine transporter inhibitors for use in treatment of movement disorders and other CNS indications | PREXA PHARMACEUTICALS, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| US-20120088307-A1 | Methods and Compositions for Analyzing Proteins | MONOGRAM BIOSCIENCES, INC. (US) | 2012-04-12 | — | — | US | disclosed |
| US-8101375-B2 | Compositions and methods for detecting phosphomonoester | ILLUMINA, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| EP-0726322-B2 | Homocysteine assay | AXIS SHIELD ASA (NO) | 2011-12-07 | — | — | EP | disclosed |
| WO-2011140376-A1 | CONTROLLED DRUG RELEASE FROM DENDRIMERS | PROLYNX LLC (US) | 2011-11-10 | — | — | WO | disclosed |
| WO-2011140392-A1 | CONTROLLED DRUG RELEASE FROM SOLID SUPPORTS | PROLYNX LLC (US) | 2011-11-10 | — | — | WO | disclosed |
| EP-1509489-B1 | AMINES THAT INHIBIT A MAMMALIAN ANANDAMIDE TRANSPORTER, AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC (US) | 2011-07-13 | — | — | EP | disclosed |
| EP-2338881-A1 | Dopamine transporter inhibitors for use in treatment of movement disorders and other CNS indications | Prexa Pharmaceuticals, Inc. (US) | 2011-06-29 | — | — | EP | disclosed |
| EP-2336783-A1 | C-terminal sequencing of amino acids | BASF SE (DE) | 2011-06-22 | — | — | EP | disclosed |
| US-20110020853-A1 | COMPOSITIONS AND METHODS FOR DETECTING PHOSPHOMONOESTER | ILLUMINA, INC. (US) | 2011-01-27 | — | — | US | disclosed |
| EP-2260839-A2 | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors | Merz Pharma GmbH & Co. KGaA (DE) | 2010-12-15 | — | — | EP | disclosed |
| US-7816375-B2 | Ligands for monoamine receptors and transporters, and methods of use thereof | SEPRACOR INC. (US) | 2010-10-19 | — | — | US | disclosed |
| US-7812035-B2 | 4-substituted piperidines, and methods of use thereof | SEPRACOR INC. (US) | 2010-10-12 | — | — | US | disclosed |
| US-7811775-B2 | Fluorescence polarization-based homogenous assay for aflatoxins | DIACHEMIX LLC (US) | 2010-10-12 | — | — | US | disclosed |
| US-7803751-B2 | Compositions and methods for detecting phosphomonoester | ILLUMINA, INC. (US) | 2010-09-28 | — | — | US | disclosed |
| US-20100227852-A1 | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-09-09 | — | — | US | disclosed |
| US-20100217727-A1 | Dopamine Transporter Inhibitors for Use in Treatment of Movement Disorders and Other CNS Indications | Prexa Pharmaceuticals, Inc. c/o Advent Healthcare Ventures (US) | 2010-08-26 | — | — | US | disclosed |
| US-20100093706-A1 | MULTIMEDIATOR TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | PREXA PHARMACEUTICALS, INC. (US) | 2010-04-15 | — | — | US | disclosed |
| US-7671087-B2 | Amines that inhibit a mammalian anandamide transporter, and methods of use thereof | SEPRACOR INC. (US) | 2010-03-02 | — | — | US | disclosed |
| US-20100028451-A1 | SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASE | TRUSTEES OF TUFTS COLLEGE (US) | 2010-02-04 | — | — | US | disclosed |
| CN-101573334-A | Multi-mediator transporter inhibitors for the treatment of central nervous system disorders | PREXA PHARMACEUTICALS INC (US) | 2009-11-04 | — | — | CN | disclosed |
| US-20090258901-A1 | LIGANDS FOR MONOAMINE RECEPTORS AND TRANSPORTERS, AND METHODS OF USE THEREOF | AQUILA BRIAN M | 2009-10-15 | — | — | US | disclosed |
| US-7592143-B2 | Methods of treating diseases responsive to induction of apoptosis and screening assays | CYTOVIA, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| EP-1540347-B1 | DETECTING RECEPTOR OLIGOMERIZATION | ACLARA BIOSCIENCES INC (US) | 2009-09-09 | — | — | EP | disclosed |
| US-20090163593-A1 | AMINES THAT INHIBIT A MAMMALIAN ANANDAMIDE TRANSPORTER, AND METHODS OF USE THEREOF | AQUILA BRIAN M | 2009-06-25 | — | — | US | disclosed |
| US-7550447-B2 | Method for precipitating nucleic acid with visible carrier | MERCK PATENT GMBH (DE) | 2009-06-23 | — | — | US | disclosed |
| EP-2069300-A2 | MULTIMEDIATOR TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | PREXA PHARMACEUTICALS, INC. (US) | 2009-06-17 | — | — | EP | disclosed |
| US-20090124659-A1 | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase and inhibitors | MERZ PHARMA GMBH & CO. KGAA (DE) | 2009-05-14 | — | — | US | disclosed |
| EP-1117838-B1 | A METHOD FOR ANALYZING POLYNUCLEOTIDES | VARIAGENICS INC (US) | 2009-05-13 | — | — | EP | disclosed |
| US-7517892-B2 | Ligands for monoamine receptors and transporters, and methods of use thereof | SEPRACOR INC. (US) | 2009-04-14 | — | — | US | disclosed |
| US-7511073-B2 | Amines that inhibit a mammalian anandamide transporter, and methods of use thereof | SEPRACOR, INC. (US) | 2009-03-31 | — | — | US | disclosed |
| US-7511141-B2 | Piperidine-piperazine ligands for neurotransmitter receptors | SEPRACOR, INC. (US) | 2009-03-31 | — | — | US | disclosed |
| US-20090008452-A1 | PRODUCT PACKAGING INCLUDING DIGITAL DATA | VERIFICATION TECHNOLOGIES, INC. (US) | 2009-01-08 | — | — | US | disclosed |
| US-20080311674-A1 | METHODS AND COMPOSITIONS FOR ANALYZING PROTEINS | MONOGRAM BIOSCIENCES, INC. (US) | 2008-12-18 | — | — | US | disclosed |
| US-7446115-B2 | To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide | SEPRACOR, INC. (US) | 2008-11-04 | — | — | US | disclosed |
| WO-2008118133-A2 | SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASE | TRUSTEES OF TUFTS COLLEGE (US) | 2008-10-02 | — | — | WO | disclosed |
| US-20080234247-A1 | Heterocyclic analgesic compounds and methods of use thereof | SEPRACOR, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| EP-1599492-A4 | RECEPTOR DEORPHANIZATION USING TAGGED MOLECULAR LIBRARIES | VIROLOGIC INC (US) | 2008-09-24 | — | — | EP | disclosed |
| US-20080227221-A1 | Fluorescence Polarization-Based Homogeneous Assay For Aflatoxins | DIACHEMIX, LLC (US) | 2008-09-18 | — | — | US | disclosed |
| WO-2008089487-A2 | CARBOXYETHYLPYRROLE COMPOUNDS AND METHODS OF THEIR PRODUCTION | THE CLEVELAND CLINIC FOUNDATION (US) | 2008-07-24 | — | — | WO | disclosed |
| US-7361666-B2 | Heterocyclic analgesic compounds and methods of use thereof | SEPRACOR, INC. (US) | 2008-04-22 | — | — | US | disclosed |
| CN-101163676-A | Dopamine transporter inhibitors for use in treatment of movement disorders and other cns indications | PREXA PHARMACEUTICALS INC (US) | 2008-04-16 | — | — | CN | disclosed |
| EP-1620564-A4 | METHODS OF TREATING DISEASES RESPONSIVE TO INDUCTION OF APOPTOSIS AND SCREENING ASSAYS | CYTOVIA INC (US) | 2008-03-12 | — | — | EP | disclosed |
| EP-1456657-A4 | TAGGED MICROPARTICLE COMPOSITIONS AND METHODS | ACLARA BIOSCIENCES INC (US) | 2008-03-12 | — | — | EP | disclosed |
| WO-2008024371-A2 | MULTIMEDIATOR TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | PREXA PHARMACEUTICALS, INC. (US) | 2008-02-28 | — | — | WO | disclosed |
| US-20080050812-A1 | Micropositioning Cells For Tissue Engineering | COX JAMES W | 2008-02-28 | — | — | US | disclosed |
| EP-1581796-A4 | MULTIPLEX ANALYTICAL PLATFORM USING MOLECULAR TAGS | ACLARA BIOSCIENCES INC (US) | 2008-02-13 | — | — | EP | disclosed |
| US-20080011853-A1 | Product Packaging Including Digital Data | VERIFICATION TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | US | disclosed |
| EP-1853560-A1 | DOPAMINE TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF MOVEMENT DISORDERS AND OTHER CNS INDICATIONS | Psychenomics, Inc. (US) | 2007-11-14 | — | — | EP | disclosed |
| US-7294637-B2 | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter | SEPRACOR, INC. (US) | 2007-11-13 | — | — | US | disclosed |
| US-20070225331-A1 | 4,4-Disubstituted piperidines, and methods of use thereof | SEPRACOR INC. (US) | 2007-09-27 | — | — | US | disclosed |
| EP-1407272-B1 | FLUORESCENCE POLARIZATION-BASED HOMOGENOUS ASSAY FOR AFLATOXINS | DIACHEMIX LLC (US) | 2007-09-12 | — | — | EP | disclosed |
| US-7255999-B2 | Detection of preferential polypetide in sample; otain sample containing preferential polyeptide, electrophorese, incubate with probe, detect signal from probe and recover polypeptide | MONOGRAM BIOSCIENCES, INC. (US) | 2007-08-14 | — | — | US | disclosed |
| US-20070178601-A1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | EMD BIOSCIENCES, INC. | 2007-08-02 | — | — | US | disclosed |
| US-7237720-B2 | Product packaging including digital data | VERIFICATION TECHNOLOGIES, INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-20070134723-A1 | Compositions and methods for detecting phosphomonoester | ILLUMINA, INC. (US) | 2007-06-14 | — | — | US | disclosed |
| US-7217531-B2 | Multiplex analysis using membrane-bound sensitizers | MONOGRAM BIOSCIENCES (US) | 2007-05-15 | — | — | US | disclosed |
| US-7217823-B2 | 4,4-Disubstituted piperidines, and methods of use thereof | SEPRACOR INC. (US) | 2007-05-15 | — | — | US | disclosed |
| US-20070093522-A1 | Peptidomimetic ligands for cellular receptors and ion channels | PERSONS PAUL E | 2007-04-26 | — | — | US | disclosed |
| EP-1634077-A4 | MICROPOSITIONING CELLS FOR TISSUE ENGINEERING | UNIV TEXAS (US) | 2007-03-28 | — | — | EP | disclosed |
| EP-1509489-A4 | AMINES THAT INHIBIT A MAMMALIAN ANANDAMIDE TRANSPORTER, AND METHODS OF USE THEREOF | SEPRACOR INC (US) | 2007-03-21 | — | — | EP | disclosed |
| US-7160735-B2 | Tagged microparticle compositions and methods | MONOGRAM BIOSCIENCES, INC. (US) | 2007-01-09 | — | — | US | disclosed |
| US-20070001011-A1 | Product packaging including digital data | VERIFICATION TECHNOLOGIES, INC. (US) | 2007-01-04 | — | — | US | disclosed |
| CN-1291034-C | Method for identifying polymorphisms | VARY GENIX CORP (US) | 2006-12-20 | — | — | CN | disclosed |
| US-20060281742-A1 | Amines that inhibit a mammalian anandamide transporter, and methods of use thereof | AQUILA BRIAN M | 2006-12-14 | — | — | US | disclosed |
| EP-1478765-A4 | MULTIPLEX ANALYSIS USING MEMBRANE-BOUND SENSITIZERS | ACLARA BIOSCIENCES INC (US) | 2006-12-06 | — | — | EP | disclosed |
| US-7135300-B2 | Profiling frequencies of receptor heterodimers | MONOGRAM BIOSCIENCES, INC. (US) | 2006-11-14 | — | — | US | disclosed |
| US-7132551-B2 | Ligands for monoamine receptors and transporters, and methods of use thereof | SEPRACOR INC. (US) | 2006-11-07 | — | — | US | disclosed |
| US-7129228-B2 | Heterocyclic analgesic compounds and methods of use thereof | SEPRACOR INC. (US) | 2006-10-31 | — | — | US | disclosed |
| US-7124944-B2 | Product packaging including digital data | VERIFICATION TECHNOLOGIES, INC. (US) | 2006-10-24 | — | — | US | disclosed |
| US-7115664-B2 | Peptidomimetic ligands for cellular receptors and ion channels | SEPRACOR INC. (US) | 2006-10-03 | — | — | US | disclosed |
| EP-1540347-A4 | DETECTING RECEPTOR OLIGOMERIZATION | ACLARA BIOSCIENCES INC (US) | 2006-09-20 | — | — | EP | disclosed |
| EP-1200932-B1 | AUTHENTICATION DEVICE AND METHOD OF AUTHENTICATING PRODUCTS OR PRODUCT PACKAGING | SUN CHEMICAL BV (NL) | 2006-09-13 | — | — | EP | disclosed |
| US-7105308-B2 | Detecting receptor oligomerization | MONOGRAM BIOSCIENCES, INC. (US) | 2006-09-12 | — | — | US | disclosed |
| WO-2006091697-A1 | DOPAMINE TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF MOVEMENT DISORDERS AND OTHER CNS INDICATIONS | PSYCHENOMICS, INC. (US) | 2006-08-31 | — | — | WO | disclosed |
| US-20060194785-A1 | Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof | RADEKE HEIKE | 2006-08-31 | — | — | US | disclosed |
| US-7087623-B2 | Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof | SEPRACOR INC. (US) | 2006-08-08 | — | — | US | disclosed |
| US-7079230-B1 | Portable authentication device and method of authenticating products or product packaging | SUN CHEMICAL B.V. (NL) | 2006-07-18 | — | — | US | disclosed |
| US-20060127947-A1 | Receptor deorphanization using tagged molecular libraries | MONOGRAM BIOSCIENCES, INC. | 2006-06-15 | — | — | US | disclosed |
| US-7049329-B2 | Amines that inhibit a mammalian anandamide transporter, and methods of use thereof | SEPRACOR INC. (US) | 2006-05-23 | — | — | US | disclosed |
| US-7041459-B2 | Detection of preferential polypeptides in sample; obtain sample containing polypeptides, incubate with probes, electrophorese, detect signal | MONOGRAM BIOSCIENCES, INC. (US) | 2006-05-09 | — | — | US | disclosed |
| US-7030122-B2 | 1,4-disubstituted piperazine ligands for neurotransmitter receptors | SEPRACOR INC. (US) | 2006-04-18 | — | — | US | disclosed |
| US-20060063776-A1 | Piperidine-piperazine ligands for neurotransmitter receptors | PERSONS PAUL E | 2006-03-23 | — | — | US | disclosed |
| EP-1634077-A2 | MICROPOSITIONING CELLS FOR TISSUE ENGINEERING | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-03-15 | — | — | EP | disclosed |
| CN-1245629-C | Fluorescence polarizaton-based homogenous assay for aflatoxins | DIACHEMIX LLC (US) | 2006-03-15 | — | — | CN | disclosed |
| US-6994998-B1 | Base-modified nucleotides and their use for polymorphism detection | SEQUENOM, INC. (US) | 2006-02-07 | — | — | US | disclosed |
| US-20060024846-A1 | Multiplex analysis using membrane-bound sensitizers | MONOGRAM BIOSCIENCES, INC. | 2006-02-02 | — | — | US | disclosed |
| EP-1620564-A2 | METHODS OF TREATING DISEASES RESPONSIVE TO INDUCTION OF APOPTOSIS AND SCREENING ASSAYS | Cytovia, Inc. (US) | 2006-02-01 | — | — | EP | disclosed |
| US-6992077-B2 | Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof | SEPRACOR INC. (US) | 2006-01-31 | — | — | US | disclosed |
| CN-1723134-A | Security feature for products or product packaging | SUN CHEMICAL BV (NL) | 2006-01-18 | — | — | CN | disclosed |
| EP-1599492-A2 | RECEPTOR DEORPHANIZATION USING TAGGED MOLECULAR LIBRARIES | Virologic, Inc. (US) | 2005-11-30 | — | — | EP | disclosed |
| US-20050243305-A1 | Tamper-resistant authentication mark for use in product or product packaging authentication | VIG RAKESH | 2005-11-03 | — | — | US | disclosed |
| EP-1581796-A2 | MULTIPLEX ANALYTICAL PLATFORM USING MOLECULAR TAGS | Aclara BioSciences, Inc. (US) | 2005-10-05 | — | — | EP | disclosed |
| US-6949347-B2 | Multiplex analysis using membrane-bound sensitizers | ACLARA BIOSCIENCES, INC. (US) | 2005-09-27 | — | — | US | disclosed |
| US-6946477-B2 | 3-Substituted piperidines comprising urea functionality, and methods of use thereof | SEPRACOR INC. (US) | 2005-09-20 | — | — | US | disclosed |
| EP-1407272-A4 | FLUORESCENCE POLARIZATION-BASED HOMOGENOUS ASSAY FOR AFLATOXINS | DIACHEMIX LLC (US) | 2005-09-14 | — | — | EP | disclosed |
| US-6936614-B2 | Piperidine-piperazine ligands for neurotransmitter receptors | SEPRACOR INC. (US) | 2005-08-30 | — | — | US | disclosed |
| WO-2005077463-A2 | LIGAND FOR A MONOAMINE RECEPTOR OR TRANSPORTER FOR TREATING ADDICTION OR DEPENDENCE | SEPRACOR INC. (US) | 2005-08-25 | — | — | WO | disclosed |
| EP-1556822-A1 | ON-LINE VERIFICATION OF AN AUTHENTICATION MARK APPLIED TO PRODUCTS OR PRODUCT PACKAGING | Sun Chemical B.V. (NL) | 2005-07-27 | — | — | EP | disclosed |
| EP-1556019-A2 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | Merz Pharma GmbH & Co. KGaA (DE) | 2005-07-27 | — | — | EP | disclosed |
| US-20050153128-A1 | Product packaging including digital data | SELINFREUND RICHARD H (US) | 2005-07-14 | — | — | US | disclosed |
| EP-1549502-A1 | AUTHENTICATION MARK FOR A PRODUCT OR PRODUCT PACKAGE | Sun Chemical B.V. (NL) | 2005-07-06 | — | — | EP | disclosed |
| EP-1540347-A2 | DETECTING RECEPTOR OLIGOMERIZATION | Aclara BioSciences, Inc. (US) | 2005-06-15 | — | — | EP | disclosed |
| EP-1532578-A1 | TAMPER-RESISTANT AUTHENTICATION MARK FOR USE IN PRODUCT OR PRODUCT PACKAGING AUTHENTICATION | Verification Technologies, Inc. (US) | 2005-05-25 | — | — | EP | disclosed |
| US-20050080271-A1 | Peptidomimetic ligands for cellular receptors and ion channels | SEPRACOR INC. | 2005-04-14 | — | — | US | disclosed |
| US-20050080078-A1 | Method of treating addiction or dependence using a ligand for a monoamine receptor or transporter | SEPRACOR, INC. (US) | 2005-04-14 | — | — | US | disclosed |
| US-6872716-B2 | Antipsychotic sulfonamide-heterocycles, and methods of use thereof | SEPRACOR, INC. (US) | 2005-03-29 | — | — | US | disclosed |
| US-20050053972-A1 | Method for identifying polymorphisms | STANTON VINCE P (US) | 2005-03-10 | — | — | US | disclosed |
| US-20050048553-A1 | Multiplexed analysis by chromatographic separation of molecular tags | CHENNA AHMED (US) | 2005-03-03 | — | — | US | disclosed |
| EP-1509489-A1 | AMINES THAT INHIBIT A MAMMALIAN ANANDAMIDE TRANSPORTER, AND METHODS OF USE THEREOF | Sepracor, Inc. (US) | 2005-03-02 | — | — | EP | disclosed |
| US-20050038011-A1 | Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof | RADEKE HEIKE (US) | 2005-02-17 | — | — | US | disclosed |
| EP-1506399-A2 | METHODS AND COMPOSITIONS FOR ANALYZING PROTEINS | Aclara BioSciences, Inc. (US) | 2005-02-16 | — | — | EP | disclosed |
| US-6855500-B2 | For detecting single nucleotide polymorphisms (SNPs) in diploid organisms using modified nucleotides/residues | SEQUENOM, INC. (US) | 2005-02-15 | — | — | US | disclosed |
| CN-1575494-A | Product packaging including digital data | VERIFICATION TECHNOLOGIES INC (US) | 2005-02-02 | — | — | CN | disclosed |
| US-20050004026-A1 | Methods of treating diseases responsive to induction of Apoptosis and screening assays | CYTOVIA, INC. | 2005-01-06 | — | — | US | disclosed |
| WO-2004108888-A2 | MICROPOSITIONING CELLS FOR TISSUE ENGINEERING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-12-16 | — | — | WO | disclosed |
| US-20040254195-A1 | Piperidine-piperazine ligands for neurotransmitter receptors | PERSONS PAUL E (US) | 2004-12-16 | — | — | US | disclosed |
| US-6825009-B2 | HYBRID POLYNUCLEOTIDES; LABELING | VARIAGENICS, INC. | 2004-11-30 | — | — | US | disclosed |
| US-20040235913-A1 | Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof | CUNY GREGORY D (US) | 2004-11-25 | — | — | US | disclosed |
| US-20040235832-A1 | ANTIPSYCHOTIC SULFONAMIDE-HETEROCYCLES, AND METHODS OF USE THEREOF | WU XINHE (US) | 2004-11-25 | — | — | US | disclosed |
| EP-1478765-A1 | MULTIPLEX ANALYSIS USING MEMBRANE-BOUND SENSITIZERS | Aclara BioSciences, Inc. (US) | 2004-11-24 | — | — | EP | disclosed |
| WO-2004094647-A2 | METHODS OF TREATING DISEASES RESPONSIVE TO INDUCTION OF APOPTOSIS AND SCREENING ASSAYS | CYTOVIA, INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| US-20040209846-A1 | Heterocyclic analgesic compounds and methods of use thereof | CUNY GREGORY D (US) | 2004-10-21 | — | — | US | disclosed |
| US-20040197835-A1 | Profiling frequencies of receptor heterodimers | MONOGRAM BIOSCIENCES, INC. | 2004-10-07 | — | — | US | disclosed |
| US-20040191703-A1 | Photoresist-free micropatterning on polymer surfaces | AUTOGRID SYSTEMS, INC. | 2004-09-30 | — | — | US | disclosed |
| EP-1456657-A1 | TAGGED MICROPARTICLE COMPOSITIONS AND METHODS | Aclara BioSciences, Inc. (US) | 2004-09-15 | — | — | EP | disclosed |
| CN-1527942-A | Fluorescence polarization-based homogeneous aflatoxin detection method | ���Ǿ� | 2004-09-08 | — | — | CN | disclosed |
| US-6777188-B2 | DETERMINING THE GENOTYPE OF DIPLOID ORGANISM; OBTAIN ALLELES OF TARGET GENES, INCUBATE WITH PRIMERS, AMPLIFY, DETECT SIGNAL, CLASSIFY HYBRIDIZATION PATTERN | VARIAGENICS, INC. | 2004-08-17 | — | — | US | disclosed |
| WO-2004066908-A2 | COMPOSITION CONTAINING CATIONIC LIPIDS AND A POLYNUCLEOTIDE OR A POLYPEPTIDE AND METHOD FOR THE TARGETED DELIVERY OF ACTIVE SUBSTANCES | SANOFI PASTEUR (FR) | 2004-08-12 | — | — | WO | disclosed |
| WO-2004068116-A2 | RECEPTOR DEORPHANIZATION USING TAGGED MOLECULAR LIBRARIES | ACLARA BIOSCIENCES, INC. (US) | 2004-08-12 | — | — | WO | disclosed |
| US-20040152667-A1 | 4-Alkenylthiazoles comprising epoxide functionality, and methods of use thereof | BEYOND GENOMICS, INC. | 2004-08-05 | — | — | US | disclosed |
| WO-2004063700-A2 | MULTIPLEX ANALYTICAL PLATFORM USING MOLECULAR TAGS | ACLARA BIOSCIENCES, INC. (US) | 2004-07-29 | — | — | WO | disclosed |
| US-20040142974-A1 | 4,4-disubstituted piperidines, and methods of use thereof | HOEMANN MICHAEL Z (US) | 2004-07-22 | — | — | US | disclosed |
| US-6762177-B2 | FOR MODULATING THE ACTIVITY OF A G-PROTEIN-COUPLED RECEPTOR OR A SIGMA RECEPTOR IN A MAMMAL; FOR TREATING INFLAMMATORY PAIN, NEUROPATHIC PAIN, MULTIPLE SCLEROSIS, ANXIETY, DEPRESSION, PSYCHOSIS, STROKE, MOTOR NEURON DISEASE | SEPRACOR, INC. | 2004-07-13 | — | — | US | disclosed |
| US-20040126818-A1 | Detecting receptor oligomerization | MONOGRAM BIOSCIENCES, INC. | 2004-07-01 | — | — | US | disclosed |
| WO-2004037250-A1 | 4-ALKENYLTHIAZOLES COMPRISING EPOXIDE FUNCTIONALITY, AND METHODS OF USE THEREOF | BEYOND GENOMICS, INC. (US) | 2004-05-06 | — | — | WO | disclosed |
| WO-2004038645-A1 | ON-LINE VERIFICATION OF AN AUTHENTICATION MARK APPLIED TO PRODUCTS OR PRODUCT PACKAGING | SUN CHEMICAL B.V. (NL) | 2004-05-06 | — | — | WO | disclosed |
| WO-2004037234-A2 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2004-05-06 | — | — | WO | disclosed |
| US-20040087658-A1 | Synergistic mixture; Alzheimer's disease therapy | MERZ PHARMA GMBH & CO. KGAA (DE) | 2004-05-06 | — | — | US | disclosed |
| US-20040077706-A1 | Ligands for monoamine receptors and transporters, and methods of use thereof | AQUILA BRIAN M (US) | 2004-04-22 | — | — | US | disclosed |
| WO-2004033228-A1 | AUTHENTICATION MARK FOR A PRODUCT OR PRODUCT PACKAGE | SUN CHEMICAL B.V. (NL) | 2004-04-22 | — | — | WO | disclosed |
| EP-1407272-A1 | FLUORESCENCE POLARIZATION-BASED HOMOGENOUS ASSAY FOR AFLATOXINS | Diachemix LLC (US) | 2004-04-14 | — | — | EP | disclosed |
| EP-0853680-B1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | EMD BIOSCIENCES INC (US) | 2004-03-31 | — | — | EP | disclosed |
| US-6713479-B2 | LIGANDS FOR DOPAMINE, SEROTONIN OR NOREPINEPHRINE RECEPTORS OR TRANSPORTERS | SEPRACOR INC. | 2004-03-30 | — | — | US | disclosed |
| US-20040048907-A1 | Amines that inhibit a mammalian anandamide transporter, and methods of use thereof | SEPRACOR INC. | 2004-03-11 | — | — | US | disclosed |
| US-6703383-B2 | HETEROCYCLIC COMPOUNDS COMPRISING A SULFONAMIDE GROUP TO TREAT DISEASES SUCH AS PSYCHOLOGICAL DISORDERS CAUSED BY ONE OR MORE PROTEIN-G COUPLED RECEPTORS OR LIGAND -GATED ION CHANNELS | SEPRACOR, INC. | 2004-03-09 | — | — | US | disclosed |
| US-6699866-B2 | FOR THERAPY OF ADDICTION, ANXIETY, DEPRESSION, SEXUAL DYSFUNCTION, HYPERTENSION, MIGRAINE, ALZHEIMER'S DISEASE, OBESITY, EMESIS, PSYCHOSIS, ANALGESIA, SCHIZOPHRENIA, PARKINSON'S DISEASE, RESTLESS LEG SYNDROME, SLEEPING DISORDERS | SEPRACOR INC. | 2004-03-02 | — | — | US | disclosed |
| US-20040038983-A1 | 3-aza- and 1,4-diaza-bicyclo[4.3.0]nonanes, and methods of use thereof | SEPRACOR INC. | 2004-02-26 | — | — | US | disclosed |
| WO-2004013805-A1 | TAMPER-RESISTANT AUTHENTICATION MARK FOR USE IN PRODUCT OR PRODUCT PACKAGING AUTHENTICATION | VERIFICATION TECHNOLOGIES, INC. D/B/A VERITEC (US) | 2004-02-12 | — | — | WO | disclosed |
| WO-2004011900-A2 | DETECTING RECEPTOR OLIGOMERIZATION | ACLARA BIOSCIENCES, INC. (US) | 2004-02-05 | — | — | WO | disclosed |
| US-20040023397-A1 | Tamper-resistant authentication mark for use in product or product packaging authentication | VERIFICATION TECHNOLOGIES, INC. | 2004-02-05 | — | — | US | disclosed |
| WO-2004007445-A2 | PROTEIN KINASE C MODULATORS, AND METHODS OF USE THEREOF | GEORGETOWN UNIVERSITY (US) | 2004-01-22 | — | — | WO | disclosed |
| US-6677332-B1 | AMIDE-SUBSTITUTED PIPERIDINE OR AZEPINE DERIVATIVES TO TREAT DRUG ABUSE AND TINNITUS | SEPRACOR, INC. | 2004-01-13 | — | — | US | disclosed |
| US-20040000787-A1 | Authentication mark for a product or product package | SUN CHEMICAL B.V. (AN) | 2004-01-01 | — | — | US | disclosed |
| US-20030235832-A1 | Multiplexed analysis by chromatographic separation of molecular tags | CHENNA AHMED (US) | 2003-12-25 | — | — | US | disclosed |
| US-20030236283-A1 | 4-Substituted piperidines, and methods of use thereof | SEPRACOR INC. | 2003-12-25 | — | — | US | disclosed |
| CN-1463292-A | Method for analyzing polynucleotide | VARY GENIX CORP (US) | 2003-12-24 | — | — | CN | disclosed |
| US-6656953-B2 | Ligands for receptors such as dopamine, serotonin, or norepinephrine transporters; broad uses claimed, such as pain reliever and antidepressant | SEPRACOR INC. | 2003-12-02 | — | — | US | disclosed |
| WO-2003097573-A1 | AMINES THAT INHIBIT A MAMMALIAN ANANDAMIDE TRANSPORTER, AND METHODS OF USE THEREOF | SEPRACOR, INC. (US) | 2003-11-27 | — | — | WO | disclosed |
| US-6645980-B1 | Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals | SEPRACOR INC. | 2003-11-11 | — | — | US | disclosed |
| US-20030207300-A1 | Multiplex analytical platform using molecular tags | MONOGRAM BIOSCIENCES, INC. | 2003-11-06 | — | — | US | disclosed |
| WO-2003086393-A1 | 3-AZA- AND 1,4-DIAZA-BICYCLO[4.3.0]NONANES, AND METHODS OF USE THEREOF | SEPRACOR, INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| US-6635661-B2 | Piperidinyl amide compounds | SEPRACOR INC. | 2003-10-21 | — | — | US | disclosed |
| WO-2002094998-A9 | ANALYZING PHOSPHORYLATED PROTEINS | ACLARA BIOSCIENCES INC (US) | 2003-10-09 | — | — | WO | disclosed |
| US-6623860-B2 | Multilevel flow structures | ACLARA BIOSCIENCES, INC. | 2003-09-23 | — | — | US | disclosed |
| WO-2003076649-A1 | MULTIPLEX ANALYSIS USING MEMBRANE-BOUND SENSITIZERS | ACLARA BIOSCIENCES, INC. (US) | 2003-09-18 | — | — | WO | disclosed |
| US-20030171355-A1 | Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof | RADEKE HEIKE (US) | 2003-09-11 | — | — | US | disclosed |
| US-20030170915-A1 | Multiplex analysis using membrane-bound sensitizers | MONOGRAM BIOSCIENCES, INC. | 2003-09-11 | — | — | US | disclosed |
| US-20030165880-A1 | Fluorescence-based genotyping | NUVELO, INC. | 2003-09-04 | — | — | US | disclosed |
| US-6610492-B1 | The present invention is directed to novel base-modified nucleotides and methods for their use in the preparation and cleavage of modified polynucleotides. | VARIAGENICS, INC. | 2003-08-26 | — | — | US | disclosed |
| US-20030134290-A1 | Method for identifying polymorphisms | NUVELO, INC. | 2003-07-17 | — | — | US | disclosed |
| US-20030134333-A1 | Tagged microparticle compositions and methods | MONOGRAM BIOSCIENCES, INC. | 2003-07-17 | — | — | US | disclosed |
| US-6582923-B2 | Determination of nucleotide sequences | VARIAGENICS, INC. | 2003-06-24 | — | — | US | disclosed |
| WO-2003049736-A1 | 4-SUBSTITUTED PIPERIDINES, AND METHODS OF USE THEREOF | SEPRACOR, INC. (US) | 2003-06-19 | — | — | WO | disclosed |
| US-20030114436-A1 | 3-substituted piperidines comprising urea functionality, and methods of use thereof | AQUILA BRIAN M (US) | 2003-06-19 | — | — | US | disclosed |
| US-20030112423-A1 | On-line verification of an authentication mark applied to products or product packaging | VERIFICATION TECHNOLOGIES, INC. | 2003-06-19 | — | — | US | disclosed |
| EP-1318988-A2 | LIGANDS FOR MONOAMINE RECEPTORS AND TRANSPORTERS, AND METHODS OF USE THEREOF (NEUROTRANSMISSION) | Sepracor, Inc. (US) | 2003-06-18 | — | — | EP | disclosed |
| US-20030105071-A1 | Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof | SEPRACOR INC. | 2003-06-05 | — | — | US | disclosed |
| WO-2003042699-A1 | TAGGED MICROPARTICLE COMPOSITIONS AND METHODS | ACLARA BIOSCIENCES INC. (US) | 2003-05-22 | — | — | WO | disclosed |
| WO-2003042398-A2 | MULTIPLEXED ANALYSIS BY CHROMATOGRAPHIC SEPARATION OF MOLECULAR TAGS | ACLARA BIOSCIENCES, INC. (US) | 2003-05-22 | — | — | WO | disclosed |
| US-6566059-B1 | Method for analyzing polynucleotides | VARIAGENICS, INC. | 2003-05-20 | — | — | US | disclosed |
| US-20030087398-A1 | Method for analyzing polynucleotides | NUVELO, INC. | 2003-05-08 | — | — | US | disclosed |
| US-20030073681-A1 | 2-substituted piperidines that are ligands for monoamine receptors and transporters | SEPRACOR INC. | 2003-04-17 | — | — | US | disclosed |
| EP-0726322-B1 | Homocysteine assay | AXIS SHIELD ASA (NO) | 2003-04-16 | — | — | EP | disclosed |
| US-20030069418-A1 | Heterocyclic analgesic compounds and methods of use thereof | SEPRACOR, INC. | 2003-04-10 | — | — | US | disclosed |
| US-20030050309-A1 | Ligands for monoamine receptors and transporters, and methods of use thereof | SEPRACOR INC. | 2003-03-13 | — | — | US | disclosed |
| US-20030040016-A1 | Analyzing phosphorylated proteins | MONOGRAM BIOSCIENCES, INC. | 2003-02-27 | — | — | US | disclosed |
| WO-2003016274-A2 | 2-SUBSTITUTED PIPERIDINES THAT ARE LIGANDS FOR MONOAMINE RECEPTORS AND TRANSPORTERS | SEPRACOR, INC. (US) | 2003-02-27 | — | — | WO | disclosed |
| EP-0617791-B1 | AUTOMATED ANALYSIS EQUIPMENT AND ASSAY METHOD FOR DETECTING CELL SURFACE PROTEIN AND/OR CYTOPLASMIC RECEPTOR FUNCTION USING SAME | MERCK & CO INC (US) | 2003-02-19 | — | — | EP | disclosed |
| WO-2003006994-A1 | FLUORESCENCE POLARIZATION-BASED HOMOGENOUS ASSAY FOR AFLATOXINS | DIACHEMIX LLC (US) | 2003-01-23 | — | — | WO | disclosed |
| US-20030013126-A1 | Methods and compositions for analyzing proteins | MONOGRAM BIOSCIENCES, INC. | 2003-01-16 | — | — | US | disclosed |
| US-6500650-B1 | Method for identifying polymorphisms | VARIAGENICS, INC. | 2002-12-31 | — | — | US | disclosed |
| WO-2002095356-A2 | METHODS AND COMPOSITIONS FOR ANALYZING PROTEINS | ACLARA BIOSCIENCES, INC. (US) | 2002-11-28 | — | — | WO | disclosed |
| WO-2002094998-A2 | ANALYZING PHOSPHORYLATED PROTEINS | ACLARA BIOSCIENCES, INC. (US) | 2002-11-28 | — | — | WO | disclosed |
| US-20020177607-A1 | 4,4-Disubstitued piperidines, and methods of use thereof | SEPRACOR INC. | 2002-11-28 | — | — | US | disclosed |
| US-6476046-B1 | LIGANDS FOR G-PROTEIN-COUPLED RECEPTORS AND OPIOD RECEPTORS; ANALGESICS, TREATING DRUG ADDICTION, OR TINNITUS | SEPRACOR, INC. | 2002-11-05 | — | — | US | disclosed |
| US-6476050-B2 | ANALGESICS; LIGANDS FOR VARIOUS CELLULAR RECEPTORS, INCLUDING OPIOID RECEPTORS, OTHER G-PROTEIN-COUPLED RECEPTORS AND ION CHANNELS | SEPRACOR, INC. | 2002-11-05 | — | — | US | disclosed |
| US-6476019-B1 | Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof | SEPRACOR INC. | 2002-11-05 | — | — | US | disclosed |
| WO-2002083863-A2 | THIAZOLE AND OTHER HETEROCYCLIC LIGANDS AND USE THEREOF | SEPRACOR, INC. (US) | 2002-10-24 | — | — | WO | disclosed |
| WO-2002083071-A2 | HETEROCYCLIC ANALGESIC COMPOUNDS AND METHODS OF USE THEREOF | SEPRACOR, INC. (US) | 2002-10-24 | — | — | WO | disclosed |
| US-20020156092-A1 | Diazabicyclo[4.3.0]nonanes, and methods of use thereof | SEPRACOR INC. | 2002-10-24 | — | — | US | disclosed |
| US-20020150943-A1 | Genotyping by mass spectrometric analysis of allelic fragments | VARIAGENICS, INC. | 2002-10-17 | — | — | US | disclosed |
| US-6458945-B1 | DETECTING VARIANCE IN NUCLEOTIDE SEQUENCE; MIXING ADENOSINE-CYTOSINE-, THYMIDINE-, OR URIDINE TRIPHOSPHATE WITH NUCLEOTIDE IN PRESENCE OF POLYMERASE | VARIAGENICS, INC. | 2002-10-01 | — | — | US | disclosed |
| WO-2002069895-A2 | HETEROCYCLIC ANALGESIC COMPOUNDS AND METHODS OF USE THEREOF | SEPRACOR, INC. (US) | 2002-09-12 | — | — | WO | disclosed |
| US-20020123499-A1 | Piperidine-piperazine ligands for neurotransmitter receptors | SEPRACOR INC. | 2002-09-05 | — | — | US | disclosed |
| US-6440705-B1 | DETECTION OF VARIANCE IN NUCLEOTIDE SEQUENCE WITHOUT THE NEED FOR FULL SEQUENCE DETERMINATION; GENOTYPING AND LABELING WHILE CLEAVING DNA STRANDS; ELECTROPHORESIS | NUVELO, INC. | 2002-08-27 | — | — | US | disclosed |
| WO-2001006453-A9 | PORTABLE AUTHENTICATION DEVICE AND METHOD OF AUTHENTICATING PRODUCTS OR PRODUCT PACKAGING | VERIFICATION TECHNOLOGIES INC (US) | 2002-07-25 | — | — | WO | disclosed |
| CN-1360711-A | Method for authenticating a product or product packaging and portable authentication device | VERIFICATION TECHNOLOGIES INC (US) | 2002-07-24 | — | — | CN | disclosed |
| US-20020074271-A1 | Multilevel flow structures | MONOGRAM BIOSCIENCES, INC. | 2002-06-20 | — | — | US | disclosed |
| WO-2002046156-A2 | 4,4-DISUBSTITUTED PIPERIDINES FOR USE AS DOPAMINE, SEROTONIN AND NOREPINEPHRINE LIGANDS | SEPRACOR, INC. (US) | 2002-06-13 | — | — | WO | disclosed |
| US-20020065265-A1 | Antipsychotic sulfonamide-heterocycles, and methods of use thereof | SEPRACOR INC. | 2002-05-30 | — | — | US | disclosed |
| US-6372183-B1 | Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same | MERCK & CO., INC. | 2002-04-16 | — | — | US | disclosed |
| WO-2002022579-A2 | ANTIPSYCHOTIC SULFONAMIDE-HETEROCYCLES, AND METHODS OF USE THEREOF | SEPRACOR, INC. (US) | 2002-03-21 | — | — | WO | disclosed |
| WO-2002022572-A2 | LIGANDS FOR MONOAMINE RECEPTORS AND TRANSPORTERS, AND METHODS OF USE THEREOF (NEUROTRANSMISSION) | SEPRACOR, INC. (US) | 2002-03-21 | — | — | WO | disclosed |
| EP-1187810-A2 | HETEROCYCLIC ANALGESIC COMPOUNDS AND THEIR USE | SEPRACOR, INC. (US) | 2002-03-20 | — | — | EP | disclosed |
| WO-2002021098-A2 | A METHOD FOR IDENTIFYING POLYMORPHISMS | VARIAGENICS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002018922-A2 | HIGH-THROUGHPUT METHOD FOR DETERMINING THE ENANTIOMERIC PURITY OF CHIRAL COMPOUNDS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-03-07 | — | — | WO | disclosed |
| US-20020016337-A1 | Heterocyclic analgesic compounds and methods of use thereof | SEPRACOR INC. | 2002-02-07 | — | — | US | disclosed |
| US-20010056090-A1 | 3-substituted piperidines comprising urea functionality, and methods of use thereof | SEPRACOR INC. | 2001-12-27 | — | — | US | disclosed |
| WO-2001092226-A1 | HETEROCYCLIC ANALGESIC COMPOUNDS AND METHOD OF USE THEREOF | SEPRACOR, INC. (US) | 2001-12-06 | — | — | WO | disclosed |
| WO-2001070684-A2 | PEPTIDOMIMETIC LIGANDS FOR CELLULAR RECEPTORS AND ION CHANNELS | SEPRACOR, INC. (US) | 2001-09-27 | — | — | WO | disclosed |
| WO-2001068604-A2 | 3-SUBSTITUTED PIPERIDINES COMPRISING UREA FUNCTIONALITY, AND METHODS OF USE THEREOF | SEPRACOR, INC. (US) | 2001-09-20 | — | — | WO | disclosed |
| US-6229055-B1 | SYNTHESIS OF FLUORINATED RESORCINOL WHICH IS USEFUL IN THE PREPARATION OF FLUORINATED FLUORESCEIN AND RHODOL DYES SUITABLE FOR USE AS TRACERS, LABELS, OR INTERMEDIATES | MOLECULAR PROBES, INC. | 2001-05-08 | — | — | US | disclosed |
| WO-2001012630-A1 | SPIROCYCLIC LIGANDS FOR SIGMA RECEPTORS, AND LIBRARIES AND METHODS OF USE THEREOF | SEPRACOR INC. (US) | 2001-02-22 | — | — | WO | disclosed |
| US-6162931-A | Fluorinated xanthene derivatives | MOLECULAR PROBES, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| WO-2000071518-A2 | HETEROCYCLIC ANALGESIC COMPOUNDS AND THEIR USE | SEPRACOR, INC. (US) | 2000-11-30 | — | — | WO | disclosed |
| US-6127133-A | DETECTING MODULATORS OF IONIC MOBILITY; INSERTION OF CELL FILLED MULTICOMPARTMENT VESSEL INTO APPARATUS, INCUBATING WITH MODULATOR, DETECTING AND MEASURING FLUORESCENCE | SIBIA NEUROSCIENCES, INC. (US) | 2000-10-03 | — | — | US | disclosed |
| WO-2000056707-A1 | DIARYL THIOETHERS, COMPOSITIONS AND USES THEREOF | SEPRACOR, INC. (US) | 2000-09-28 | — | — | WO | disclosed |
| EP-0853680-A4 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN INC (US) | 2000-09-13 | — | — | EP | disclosed |
| US-6063581-A | DETECTING COMPOUND IN SAMPLE USING ANTIBODIES; INCUBATION OF SAMPLE WITH HYDROLASE ENZYME AND ADENOSINE, DETECTING THE PRESENCE OF PRODUCTS WITH HAPTENS AND MONOCLONAL ANTIBODIES | AXIS-SHIELD ASA (NO) | 2000-05-16 | — | — | US | disclosed |
| US-6057114-A | MONITORING IONIC MOBILITY THROUGH CHANNELS OR RECEPTORS; USING MULTICOMPARTMENT APPARATUS TO DELIVER TO ONE OR MORE COMPARTMENTS A MODULATOR, MONITOR FLUORESCENT EMISSIONS IN COMPARTMENTS | SIBIA NEUROSCIENCES, INC. (US) | 2000-05-02 | — | — | US | disclosed |
| US-6022597-A | COATING POLYESTER CORD WITH PERHALOPHENYLAZIDE SOLUTION, EXPOSING THE COATED CORD TO AN ENERGY SOURCE AND/OR HEATING THE POLYESTER CORD COATED WITH THE PERHALOPHENYLAZIDE TO A TEMPERATURE OF FROM ABOUT 130-200 DEGREES C | YAN MINGDI (US) | 2000-02-08 | — | — | US | disclosed |
| US-5958717-A | Immunoassay for homocysteine | AXIS BIOCHEMICALS ASA (NO) | 1999-09-28 | — | — | US | disclosed |
| EP-0549752-B1 | PROTEIN SEQUENCING | BECKMAN COULTER INC (US) | 1999-03-17 | — | — | EP | disclosed |
| EP-0884324-A2 | Method for generating an anilinothiozolinone by treatment of a phenylthiocarbamyl amino acid with a Lewis acid in protein sequencing | Beckman Coulter, Inc. (US) | 1998-12-16 | — | — | EP | disclosed |
| US-5830539-A | Methods for functionalizing and coating substrates and devices made according to the methods | THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 1998-11-03 | — | — | US | disclosed |
| US-5827645-A | Homocysteine assay | AXIS BIOCHEMICALS AS (NO) | 1998-10-27 | — | — | US | disclosed |
| EP-0853680-A1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN, INC. (US) | 1998-07-22 | — | — | EP | disclosed |
| WO-1998022541-A2 | METHOD FOR COATING SUBSTRATES | IKONOS CORPORATION (US) | 1998-05-28 | — | — | WO | disclosed |
| WO-1998022542-A2 | CHEMICAL FUNCTIONALIZATION OF SURFACES | IKONOS CORPORATION (US) | 1998-05-28 | — | — | WO | disclosed |
| US-5670113-A | COMPUTER CONTROLLED FLUORESCENCE MEASURING APPARATUS | SIBIA NEUROSCIENCES, INC. (US) | 1997-09-23 | — | — | US | disclosed |
| EP-0731909-A4 | SENSORS EMPLOYING INTERFERENCE OF ELECTROMAGNETIC WAVES PASSING THROUGH WAVEGUIDES HAVING FUNCTIONALIZED SURFACES | OREGON STATE (US) | 1997-09-03 | — | — | EP | disclosed |
| US-5631127-A | Enzymatic assay for homocysteine and a kit therefor | AXIS BIOCHEMICALS AS (NO) | 1997-05-20 | — | — | US | disclosed |
| WO-1997012994-A1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN, INC. (US) | 1997-04-10 | — | — | WO | disclosed |
| US-5582955-A | Chemical functionalization of surfaces | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 1996-12-10 | — | — | US | disclosed |
| US-5580697-A | Chemical functionalization of surfaces | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 1996-12-03 | — | — | US | disclosed |
| EP-0731909-A1 | SENSORS EMPLOYING INTERFERENCE OF ELECTROMAGNETIC WAVES PASSING THROUGH WAVEGUIDES HAVING FUNCTIONALIZED SURFACES | THE STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATEBOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 1996-09-18 | — | — | EP | disclosed |
| EP-0623174-B1 | HOMOCYSTEINE ASSAY | AXIS BIOCHEMICALS AS (NO) | 1996-09-04 | — | — | EP | disclosed |
| EP-0726322-A1 | Homocysteine assay | AXIS BIOCHEMICALS AS (NO) | 1996-08-14 | — | — | EP | disclosed |
| EP-0680623-A4 | CHEMICAL FUNCTIONALIZATION OF SURFACES. | OREGON STATE (US) | 1996-07-24 | — | — | EP | disclosed |
| EP-0680623-A1 | CHEMICAL FUNCTIONALIZATION OF SURFACES | THE STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATEBOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 1995-11-08 | — | — | EP | disclosed |
| US-5465151-A | Sensors employing interference of electromagnetic waves passing through waveguides having functionalized surfaces | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 1995-11-07 | — | — | US | disclosed |
| EP-0623174-A1 | HOMOCYSTEINE ASSAY. | COCKBAIN JULIAN R M (GB) | 1994-11-09 | — | — | EP | disclosed |
| EP-0617791-A1 | AUTOMATED ANALYSIS EQUIPMENT AND ASSAY METHOD FOR DETECTING CELL SURFACE PROTEIN AND/OR CYTOPLASMIC RECEPTOR FUNCTION USING SAME | SIBIA NEUROSCIENCES, INC. (US) | 1994-10-05 | — | — | EP | disclosed |
| WO-1994018544-A1 | SENSORS EMPLOYING INTERFERENCE OF ELECTROMAGNETIC WAVES PASSING THROUGH WAVEGUIDES HAVING FUNCTIONALIZED SURFACES | THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 1994-08-18 | — | — | WO | disclosed |
| WO-1994017447-A1 | CHEMICAL FUNCTIONALIZATION OF SURFACES | THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 1994-08-04 | — | — | WO | disclosed |
| US-5270213-A | Protein sequencing | PORTON INSTRUMENTS, INC. (US) | 1993-12-14 | — | — | US | disclosed |
| WO-1993015220-A1 | HOMOCYSTEINE ASSAY | AXIS BIOCHEMICALS AS (NO) | 1993-08-05 | — | — | WO | disclosed |
| WO-1993013423-A1 | AUTOMATED ANALYSIS EQUIPMENT AND ASSAY METHOD FOR DETECTING CELL SURFACE PROTEIN AND/OR CYTOPLASMIC RECEPTOR FUNCTION USING SAME | THE SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES, INC. (US) | 1993-07-08 | — | — | WO | disclosed |
| EP-0549752-A1 | PROTEIN SEQUENCING | BECKMAN INSTRUMENTS, INC. (US) | 1993-07-07 | — | — | EP | disclosed |
| WO-1993000355-A1 | PROTEIN SEQUENCING | PORTON INSTRUMENTS, INC. (US) | 1993-01-07 | — | — | WO | disclosed |
| WO-1993000355-A1 | PROTEIN SEQUENCING | PORTON INSTRUMENTS, INC. (US) | 1993-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080078-A1 | Method of treating addiction or dependence using a ligand for a monoamine receptor or transporter | PNMT, TAAR1, OPRL1 | FTO 2152/4885MEN1 4263/4885MAPT 1358/4885 |
| US-20040152667-A1 | 4-Alkenylthiazoles comprising epoxide functionality, and methods of use thereof | OPRL1, HTR5A, HTR2C | FTO 1783/4885MEN1 2532/4885MAPT 915/4885 |
| US-20040209846-A1 | Heterocyclic analgesic compounds and methods of use thereof | OPRL1, TRPV1, OPRK1 | FTO 4093/4885MEN1 4530/4885MAPT 3984/4885 |
| US-20070093522-A1 | Peptidomimetic ligands for cellular receptors and ion channels | OPRL1, TRPV1, ORAI1 | FTO 3067/4885MEN1 4198/4885MAPT 3973/4885 |
| US-20030236283-A1 | 4-Substituted piperidines, and methods of use thereof | HTR2C, HTR5A, OPRL1 | FTO 2331/4885MEN1 749/4885MAPT 369/4885 |
| US-20140371260-A1 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | ACHE, BACE1, CHRNE | FTO 4067/4885MEN1 1024/4885MAPT 151/4885 |
| US-20070134723-A1 | Compositions and methods for detecting phosphomonoester | CHAMP1, PTMS, PHOSPHO1 | FTO 3839/4885MEN1 556/4885MAPT 3277/4885 |
| US-20120329829-A1 | Dopamine Transporter Inhibitors for Use in Treatment of Movement Disorders and Other CNS Indications | SLC6A3, SLC6A2, SLC18A2 | FTO 876/4885MEN1 2555/4885MAPT 205/4885 |
| US-20220389478-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | KDM1B, KDM1A, KDM7A | FTO 778/4885MEN1 2238/4885MAPT 4545/4885 |
| US-20130123487-A1 | CONTROLLED RELEASE FROM SOLID SUPPORTS | SLC43A1, ABCB1, NAPA | FTO 4436/4885MEN1 1584/4885MAPT 3020/4885 |
| US-20020177607-A1 | 4,4-Disubstitued piperidines, and methods of use thereof | HTR2C, HTR5A, OPRL1 | FTO 2368/4885MEN1 2148/4885MAPT 535/4885 |
| US-20050004026-A1 | Methods of treating diseases responsive to induction of Apoptosis and screening assays | HEATR6, HEATR1, AIP | FTO 4804/4885MEN1 4824/4885MAPT 2780/4885 |
| US-10800747-B2 | Macrocyclic compounds | SLC2A4, GALE, MPI | FTO 479/4885MEN1 724/4885MAPT 2460/4885 |
| US-20180170910-A1 | ALPHA-HELIX MIMETICS AS MODULATORS OF ABETA SELF-ASSEMBLY | APP, IAPP, BACE1 | FTO 4885/4885MEN1 821/4885MAPT 17/4885 |
| US-20030050309-A1 | Ligands for monoamine receptors and transporters, and methods of use thereof | SLC6A2, OPRL1, SLC18A2 | FTO 1459/4885MEN1 638/4885MAPT 386/4885 |
| US-20100227852-A1 | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors | ACHE, BACE1, CHRNE | FTO 4067/4885MEN1 1024/4885MAPT 151/4885 |
| US-20040038983-A1 | 3-aza- and 1,4-diaza-bicyclo[4.3.0]nonanes, and methods of use thereof | HTR2C, HTR1A, HTR5A | FTO 823/4885MEN1 1328/4885MAPT 1021/4885 |
| US-20210169864-A1 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | ACHE, PSEN1, BCHE | FTO 3611/4885MEN1 886/4885MAPT 53/4885 |
| US-20130123461-A1 | CONTROLLED DRUG RELEASE FROM DENDRIMERS | SLC43A1, SLC47A1, SLC47A2 | FTO 4857/4885MEN1 1427/4885MAPT 1847/4885 |
| US-10398779-B2 | Hydrogels with biodegradable crosslinking | IDUA, APEH, GUSB | FTO 3442/4885MEN1 2686/4885MAPT 3269/4885 |
| US-20030171355-A1 | Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof | SIGMAR1, OPRL1, GPBAR1 | FTO 4638/4885MEN1 4175/4885MAPT 4711/4885 |
| US-20020156092-A1 | Diazabicyclo[4.3.0]nonanes, and methods of use thereof | OPRL1, SIGMAR1, OPRK1 | FTO 1586/4885MEN1 4334/4885MAPT 4806/4885 |
| US-20150258204-A1 | CLICKABLE POLYOXETANE CARRIER FOR DRUG DELIVERY | DCTD, PAICS, DDOST | FTO 781/4885MEN1 2392/4885MAPT 2037/4885 |
| US-20060063776-A1 | Piperidine-piperazine ligands for neurotransmitter receptors | HTR5A, OPRL1, HTR2A | FTO 2777/4885MEN1 1403/4885MAPT 387/4885 |
| US-20140288190-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | HAAO, MMP1, SI | FTO 1632/4885MEN1 4125/4885MAPT 4051/4885 |
| US-20010056090-A1 | 3-substituted piperidines comprising urea functionality, and methods of use thereof | OPRM1, OPRL1, OPRK1 | FTO 3234/4885MEN1 4864/4885MAPT 2668/4885 |
| US-20060194785-A1 | Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof | SIGMAR1, OPRL1, GPBAR1 | FTO 4638/4885MEN1 4175/4885MAPT 4711/4885 |
| US-20230135347-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | IDUA, APEH, GUSB | FTO 3442/4885MEN1 2686/4885MAPT 3269/4885 |
| US-20030069418-A1 | Heterocyclic analgesic compounds and methods of use thereof | OPRL1, TRPV1, OPRK1 | FTO 4093/4885MEN1 4530/4885MAPT 3984/4885 |
| US-20050038011-A1 | Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof | SIGMAR1, OPRL1, GPBAR1 | FTO 4638/4885MEN1 4175/4885MAPT 4711/4885 |
| US-20040235913-A1 | Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof | HTR5A, OPRL1, HTR2C | FTO 1576/4885MEN1 988/4885MAPT 482/4885 |
| US-20170312368-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | IDUA, APEH, GUSB | FTO 3442/4885MEN1 2686/4885MAPT 3269/4885 |
| US-20040048907-A1 | Amines that inhibit a mammalian anandamide transporter, and methods of use thereof | SLC6A2, HTR2A, SLC18A1 | FTO 2761/4885MEN1 917/4885MAPT 797/4885 |
| US-20070225331-A1 | 4,4-Disubstituted piperidines, and methods of use thereof | HTR5A, HTR2C, OPRL1 | FTO 1918/4885MEN1 1787/4885MAPT 626/4885 |
| US-20020123499-A1 | Piperidine-piperazine ligands for neurotransmitter receptors | HTR5A, OPRL1, HTR2A | FTO 2777/4885MEN1 1403/4885MAPT 387/4885 |
| US-11454861-B2 | Hydrogels with biodegradable crosslinking | IDUA, APEH, GUSB | FTO 3442/4885MEN1 2686/4885MAPT 3269/4885 |
| US-10723716-B2 | Alpha-helix mimetics as modulators of Abeta self-assembly | APP, IAPP, BACE1 | FTO 4885/4885MEN1 821/4885MAPT 17/4885 |
| US-20090124659-A1 | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase and inhibitors | ACHE, BACE1, BCHE | FTO 3990/4885MEN1 1315/4885MAPT 162/4885 |
| US-20100093706-A1 | MULTIMEDIATOR TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | SLC6A4, SLC18A2, SLC6A2 | FTO 800/4885MEN1 2833/4885MAPT 233/4885 |
| US-20200399232-A1 | MACROCYCLIC COMPOUNDS | SLC2A4, GALE, MPI | FTO 479/4885MEN1 724/4885MAPT 2460/4885 |
| US-20040077706-A1 | Ligands for monoamine receptors and transporters, and methods of use thereof | SLC6A2, OPRL1, SLC18A2 | FTO 1459/4885MEN1 638/4885MAPT 386/4885 |
| US-12478680-B2 | Hydrogels with biodegradable crosslinking | IDUA, APEH, GUSB | FTO 3442/4885MEN1 2686/4885MAPT 3269/4885 |
| US-20030073681-A1 | 2-substituted piperidines that are ligands for monoamine receptors and transporters | HTR2C, HTR5A, HTR2A | FTO 1602/4885MEN1 1421/4885MAPT 480/4885 |
| US-20110020853-A1 | COMPOSITIONS AND METHODS FOR DETECTING PHOSPHOMONOESTER | CHAMP1, PTMS, PHOSPHO1 | FTO 3839/4885MEN1 556/4885MAPT 3277/4885 |
| US-20030087398-A1 | Method for analyzing polynucleotides | POLN, POLRMT, POLM | FTO 1688/4885MEN1 3272/4885MAPT 3174/4885 |
| US-20020065265-A1 | Antipsychotic sulfonamide-heterocycles, and methods of use thereof | TRPV1, CNR2, TRPM5 | FTO 4123/4885MEN1 4225/4885MAPT 2966/4885 |
| US-20030105071-A1 | Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof | HTR5A, OPRL1, HTR2C | FTO 1576/4885MEN1 988/4885MAPT 482/4885 |
| US-20160069893-A1 | Methods and Compositions for Analyzing Proteins | PTMS, ANPEP, NUDT21 | FTO 3251/4885MEN1 3763/4885MAPT 3896/4885 |
| US-20200054756-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | IDUA, APEH, GUSB | FTO 3442/4885MEN1 2686/4885MAPT 3269/4885 |
| US-20190085372-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | KDM1B, KDM1A, KDM7A | FTO 778/4885MEN1 2238/4885MAPT 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.